Version 2.78

Term Description

This term is used to report the interpretation of serology testing for SARS-CoV-2, i.e., whether the combination of two or more specific antibody results (IgG, IgM, and IgA) indicates recent or past exposure/infection.
Source: Regenstrief LOINC

Part Description

LP417540-4   SARS coronavirus 2
The 2019 Novel Coronavirus (2019-nCoV) is a coronavirus first identified as the cause of a respiratory illness outbreak in Wuhan, China. Initially, the outbreak was linked to a large seafood and animal market and thought to only be spread by animal to person contact. Within a short time, a growing number of patients who had not been exposed to animal markets were diagnosed with the infection, indicating person-to-person transmission. As of January 2020, infections with 2019-nCoV had been reported internationally due to confirmed cases in travelers from Wuhan. Overall, clinical symptoms appear milder than SARS Coronavirus (SARS-CoV) and Middle East Respiratory Syndrome (MERS) Coronavirus (MERS-CoV) infections as do the fatality rate and transmissibility. PMID: 31953166 Reported illnesses range from minor or no respiratory symptoms to severe acute respiratory illness and death.

The full genome of the 2019-nCoV was first posted by Chinese health authorities in GenBank, the NIH genetic sequence database, and in the Global Initiative on Sharing All Influenza Data (GISAI) portal. This facilitated detection of the virus globally with subsequent sequences being nearly identical, suggesting a single, recent emergence from a virus related to bat coronaviruses and the SARS coronavirus. Source: LOINC

Reference Information

Type Source Reference
Webcontent Lab Tests Online®Copyright Copyright © 2021 Lab Tests Online. All rights reserved. Coronavirus (COVID-19) Testing

Fully-Specified Name

Component
SARS coronavirus 2 Ab
Property
Imp
Time
Pt
System
Ser/Plas
Scale
Nom
Method

Additional Names

Short Name
SARS-CoV-2 Ab SerPl-Imp
Display Name
SARS-CoV-2 (COVID-19) Ab [Interp]
Consumer Name Alpha Get Info
SARS-CoV-2 (COVID-19) antibody, Blood

Ask at Order Entry

81959-9 Public health laboratory ask at order entry panel

This panel contains a convenience grouping of terms for questions commonly asked when an order is placed in a public health laboratory.

LOINC Name R/O/C Cardinality Example UCUM Units
81959-9 Public health laboratory ask at order entry panel
Indent81744-5 Submitter's laboratory test method [Type] in Specimen
Indent81658-7 Suspected organism [Identifier] in Specimen
Indent86952-9 Preliminary testing done Specimen
Indent86953-7 Preliminary testing result Specimen
Indent86955-2 Preliminary testing affected submission for further testing Specimen
Indent95417-2 Whether this is the patient's first test for condition of interest
Indent95418-0 Whether patient is employed in a healthcare setting
Indent95419-8 Whether the patient has symptoms related to condition of interest
Indent11368-8 Illness or injury onset date and time C
Indent77974-4 Whether the patient was hospitalized for condition of interest
Indent95420-6 Whether the patient was admitted to intensive care unit (ICU) for condition of interest
Indent95421-4 Whether patient resides in a congregate care setting
Indent82810-3 Pregnancy status C
Indent30525-0 Age a

Example Answer List: LL4772-1

Answer Code Score Answer ID
Ab not detected LA28480-4
Past infection LA28481-2
Recent infection LA28482-0

Basic Attributes

Class
MICRO
Type
Laboratory
First Released
Version 2.68
Last Updated
Version 2.69
Order vs. Observation
Observation

Member of these Groups Get Info

LOINC Group Group Name
LG51018-6 SARSCoV2 antibody detection

Language Variants Get Info

Tag Language Translation
de-DE German (Germany) SARS-Coronavirus 2 Ak:Interpretation:Zeitpunkt:Serum oder Plasma:Nominal:
es-ES Spanish (Spain) Panel del SARS-CoV-2 (COVID-19) Anticuerpos:Impresión/interpretación del estudio:Punto temporal:Suero o Plasma:Nom:
es-MX Spanish (Mexico) Coronavirus 2 Ab del SARS:Impresión / interpretación del estudio:Punto temporal:Suero o Plasma:Nominal:
fr-FR French (France) Coronavirus SARS-CoV-2 Ac:Interprétation:Ponctuel:Sérum/Plasma:Résultat nominal:
fr-CA French (Canada) coronavirus 2 du SRAS, Ac:Impression:Temps ponctuel:Sérum/Plasma:Nominal:
it-IT Italian (Italy) SARS coronavirus 2 Ab:Imp:Pt:Siero/Plasma:Nom:
Synonyms: anticorpo Coronavirus della SARS Impressione/interpretazione di studio Microbiologia Plasma Punto nel tempo (episodio) SARS-CoV-2 (COVID-19) Siero Siero o Plasma
nl-NL Dutch (Netherlands) SARS-CoV-2 As:interpretatie:moment:serum of plasma:nominaal:
Synonyms: antistof; antilichaam SARS-virus severe acute respiratory syndrome coronavirus 2; 2019-nCoV; 2019 novel coronavirus; COVID-19
zh-CN Chinese (China) SARS 冠状病毒 2 抗体:印象:时间点:血清/血浆:名义型:
Synonyms: 2019 新型冠状病毒;2019 年新型冠状病毒;2019-nCoV;SARS-CoV-2;新型冠状病毒肺炎;新冠肺炎;Coronavirus disease 2019;COVID-19;冠状病毒疾病2019;严重急性呼吸综合征;severe acute respiratory syndrome;SARS;传染性非典型肺炎;infectious atypical pneumonia;非典 Ⅱ Ab;自身抗体 II SARS;SARS 病毒;SARS-CoV;严重急性呼吸综合征;严重急性呼吸综合征病毒;萨斯病毒;非典;非典型肺炎;非典型肺炎病毒;非典病毒 分类型应答;分类型结果;名义性;名称型;名词型;名词性;标称性;没有自然次序的名义型或分类型应答 印象是一种诊断陈述，始终是对其他某种观察指标的解释或抽象（一系列检验项目结果、一幅图像或者整个某位病人），而且几乎总是由某位专业人员产生。;检查印象;检查印象/解释;检查的印象/解释;检查解释;解释;阐释 微生物学;微生物学试验;微生物学试验（培养、DNA、抗原及抗体） 时刻;随机;随意;瞬间 血清或血浆

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=94661-6